A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence

Clinical trial NCT00284206 · COMPLETED

Trial details

NCT number: NCT00284206
Sponsor: Seattle Institute for Biomedical and Clinical Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Methamphetamine Dependence

Start date: 2006-01-01
Primary completion: 2007-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.